Success Metrics

Clinical Success Rate
98.4%

Based on 62 completed trials

Completion Rate
98%(62/63)
Active Trials
21(17%)
Results Posted
6%(4 trials)
Terminated
1(1%)

Phase Distribution

Ph not_applicable
52
42%
Ph phase_4
42
34%
Ph early_phase_1
2
2%
Ph phase_1
7
6%
Ph phase_2
5
4%
Ph phase_3
13
10%

Phase Distribution

9

Early Stage

5

Mid Stage

55

Late Stage

Phase Distribution121 total trials
Early Phase 1First-in-human
2(1.7%)
Phase 1Safety & dosage
7(5.8%)
Phase 2Efficacy & side effects
5(4.1%)
Phase 3Large-scale testing
13(10.7%)
Phase 4Post-market surveillance
42(34.7%)
N/ANon-phased studies
52(43.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

96.9%

62 of 64 finished

Non-Completion Rate

3.1%

2 ended early

Currently Active

21

trials recruiting

Total Trials

124

all time

Status Distribution
Active(41)
Completed(62)
Terminated(2)
Other(19)

Detailed Status

Completed62
Recruiting19
unknown19
Not yet recruiting18
Enrolling by invitation2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
124
Active
21
Success Rate
98.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.7%)
Phase 17 (5.8%)
Phase 25 (4.1%)
Phase 313 (10.7%)
Phase 442 (34.7%)
N/A52 (43.0%)

Trials by Status

not_yet_recruiting1815%
enrolling_by_invitation22%
recruiting1915%
terminated11%
unknown1915%
active_not_recruiting22%
withdrawn11%
completed6250%

Recent Activity

Clinical Trials (124)

Showing 20 of 124 trialsScroll for more
NCT07717684Phase 4

Time to Loss of Consciousness With Remimazolam Versus Propofol for Anesthetic Induction in Laparoscopic Cholecystectomy

Recruiting
NCT07740343Not Applicable

Remimazolam for Postoperative Sleep in Elderly Patients

Not Yet Recruiting
NCT07740655Phase 4

Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery

Not Yet Recruiting
NCT07651956Phase 4

Remimazolam Versus Dexmedetomidine for Sedation During Neuraxial

Not Yet Recruiting
NCT07725185Not Applicable

Effects of Remimazolam on Postoperative Myocardial Injury

Enrolling By Invitation
NCT07459322Not Applicable

The Use of Remimazolam Versus Dexmedetomidine for Patients Receiving Drug-Induced Sleep Endoscopy

Not Yet Recruiting
NCT07718152Phase 4

Ciprofol and Remimazolam for Intraoperative Neurophysiological Monitoring During Spine Surgery

Not Yet Recruiting
NCT07611344Phase 4

The Effect of Remimazolam Versus Propofol on Postoperative Extubation Time

Recruiting
NCT06333145Phase 4

ED90 of Remimazolam Anesthesia Induction in Drug-induced Sleep Endoscopy in Adults

Completed
NCT06115031Not Applicable

Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients

Completed
NCT07663877Phase 4

Remimazolam-Flumazenil Versus Sevoflurane for Hysteroscopic Day Surgery

Not Yet Recruiting
NCT07269808Phase 3

Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration

Active Not Recruiting
NCT07596589Phase 3

Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU

Recruiting
NCT05160987Not Applicable

Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam

Recruiting
NCT07303985Phase 3

The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction

Completed
NCT06231563Phase 2

Ketamine for Veterans With Parkinson's Disease

Recruiting
NCT07290205Early Phase 1

Remimazolam NeuroImaging

Recruiting
NCT07251101Not Applicable

Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery

Not Yet Recruiting
NCT06180876Not Applicable

Effect of Remimazolam on Postoperative Delirium

Completed
NCT06755996Not Applicable

Dexmedetomidine Nasal Spray and Pediatric Bronchoscopy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
124